Core Laboratories (CLB) Receivables (2022 - 2026)

Core Laboratories' Receivables history runs 5 years deep, the most recent figure standing at $108.3 million for Q1 2026.

• On a quarterly basis, Receivables fell 8.08% year-over-year to $108.3 million in Q1 2026; TTM through Mar 2026 was $108.3 million, a 8.08% decrease from a year earlier, with the FY2025 full-year figure at $113.5 million, up 1.25% from the prior year.
• Receivables slipped to $108.3 million in Q1 2026 per CLB's latest filing, from $113.5 million in the prior quarter.
• Across five years, Receivables topped out at $118.2 million in Q3 2024 and bottomed at $105.2 million in Q3 2023.
• The 5-year median for Receivables is $112.1 million (2024), against an average of $112.3 million.
• Across the five-year window, Receivables rose 12.35% in 2024 and decreased 8.08% in 2026, its largest moves.
• Year by year, Receivables stood at $108.1 million in 2022, then advanced by 2.39% to $110.6 million in 2023, then climbed by 1.34% to $112.1 million in 2024, then grew by 1.25% to $113.5 million in 2025, then slipped by 4.63% to $108.3 million in 2026.
• Per Business Quant, the three latest CLB Receivables figures stand at $108.3 million (Q1 2026), $113.5 million (Q4 2025), and $111.4 million (Q3 2025).